Search keyWord :

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen's Lawsuit

Sep 19, 2024

IRVINE,Calif.,Sept. 18,2024-- Zymo Research Corporation,a leader in innovative life science solutions,acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20,2024,at the US Dis

Bloomage 2024 Mid-Year Report: Driving Growth Through Strategic Transformation to a Solutions Provider

Sep 19, 2024

PARSIPPANY,N.J.,Sept. 18,2024-- On August 23,2024,Bloomage released its mid-year financial report,reporting a revenue of RMB 2.811 billion (~USD 385 million) for the first half of the year. This succe

Hyundai Motor Group and Rhode Island School of Design Expand Partnership with Launch of New Regeneration Studio

Sep 19, 2024

Annual research collaboration examines convergence of ecology,bio-design,art and design practices,and future of mobility

French orbital rockets to launch from Arnhem Space Centre Australia in 2026

Sep 19, 2024

ADELAIDE,Australia,Sept. 18,2024-- Leading French rocket company,Sirius Space Services (Sirius),has signed with Equatorial Launch Australia (ELA) for a multi-year,multi-launch contract from the Arnhem

Alaska Airlines completes acquisition of Hawaiian Airlines, expanding benefits and choice for travelers

Sep 19, 2024

Enables guests to reach 141 destinations directly,including 29 international markets,and over 1,200 destinations globally through the oneworld Alliance and global partners

Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences

Sep 19, 2024

Stockholders must vote by 11:59 p.m. ET on September 19,2024 for their vote to count A "FOR" vote on Proposals 3 & 5 by holders of a majority of the voting power of Kintara\'s outstandi

Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI

Sep 19, 2024

ISM001-055 is a novel drug designed in-house using generative AI to target TNIK (Traf2- and NCK- interacting kinase) and has progressed through Phase IIa clinical testing.

State Grid Shizuishan Power Supply Company: "Electric" Support for Rural Revitalization and Pear Garden Fragrance

Sep 19, 2024

SHIZUISHAN,China,Sept. 18,2024-- In the golden autumn,melons and fruits are fragrant. Into the warm spring village pear garden of Chonggang town,the gentle breeze carries the fragrance of the fruitful

Reolink Launches Industry-first 2K 4MP Battery Doorbell, with 1:1 Head-to-Toe View

Sep 19, 2024

WILMINGTON,Del.,Sept. 18,2024-- Reolink,a renowned smart security solution provider,proudly announces its industry-first Smart 2K 4MP Battery Doorbell with a 1:1 aspect ratio,a powerful addition to i

VIDAA is chosen by Vestel as one of its strategic platforms, with Vestel acquiring a 4.64% stake in company

Sep 19, 2024

ATLANTA,Sept. 18,2024-- Vestel announced today that it has partnered with VIDAA as one of its strategic platforms for recurring revenues by signing an MoU to acquire a 4,64% ownership stake in the fa

1 ... 971 972 973 974 975 976 977 ... 1249